EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐Cell and Bulk Transcriptomic Profiling of Urothelial Carcinoma: Immunotherapy Associations and Functional Characterization of LY6E

Yitao Huang, Chao Zhang, Xiuzhuang Xie, Xiaye Miao iD, Zhang Quan

International Journal of Genomics · 2026-01 · 2026 (1)

DOI: 10.1155/ijog/8444243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 11.11.2026. Verfasst von Yitao Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Yongkang Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Chinese Medicine Yongkang China dlut.edu…. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Translating single‐cell immune profiles into bulk transcriptomic biomarkers requires distinguishing cell‐state signals from overall immune abundance. We evaluated the recovery and clinical relevance of single‐cell–derived immune modules in urothelial carcinoma and investigated LY6E as a candidate for functional follow‐up.

Methods

We analyzed 73,279 single cells from two GSE223971 preparations, with eight matched CD45‐enriched single‐cell/bulk pairs and six broader preparation pairs from five patients. Immune modules underwent donor‐support filtering, patient‐level validation, lineage adjustment, and comparison with reference‐profile methods. Clinical associations were assessed in GSE176307 and IMvigor210, with repeated cross‐validation used to evaluate incremental prediction in IMvigor210. An expression‐based screen followed by clinical and immune‐context assessment prioritized LY6E for knockdown and rescue experiments in 5637 and J82 cells.

Results

Thirteen of 39 annotated states met donor‐support criteria. Four modules passed the initial transfer screen, although all four 95% bootstrap intervals included zero; none of 11 testable subtypes met the within‐lineage specificity criteria. Plasma alone passed the cross‐preparation module screen (patient‐level Spearman rho = 0.900; exact p = 0.083), with weaker recovery by ProM (rho = 0.700). Its association with complete response versus progressive disease in the selected IMvigor210 subset attenuated after immune adjustment, and adding Plasma yielded no consistent predictive improvement. Several immune scores were associated with survival in unadjusted GSE176307 models without supported objective‐response associations. LY6E was upregulated in TCGA‐BLCA and GSE13507 tumors, but its associations with immunotherapy outcomes differed between cohorts. Two shRNAs reduced LY6E transcript abundance by 64%–67%, decreased growth and migration, and increased apoptosis in both cell lines. An shRNA‐resistant construct restored LY6E expression and clonogenic growth.

Conclusions

Single‐cell and bulk transcriptomic integration recovered a Plasma‐related abundance signal without establishing subtype specificity or independent immunotherapy prediction. LY6E supported growth and survival in the tested bladder cancer cell lines, whereas its relevance as an immunotherapy biomarker remains unestablished.

Schlagwörter

Stichwörter der Autor:innen

LY6Ebulk transcriptomicsimmune checkpoint inhibitionsingle-cell RNA sequencingtranscriptomic deconvolutiontumor immune microenvironmenturothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology Yongkang Hospital of Traditional Chinese Medicine Affiliated to Zhejiang University of Chinese Medicine Yongkang China dlut.edu.cn.
  • Central Laboratory Precision Medicine Center Affiliated Jinhua Hospital Zhejiang University School of Medicine Jinhua China zju.edu.cn.
  • Department of Laboratory Medicine Northern Jiangsu People's Hospital Yangzhou China yzsbh.com.
  • Department of Traditional Chinese Medicine Oncology The Affiliated Huai'an Hospital of Xuzhou Medical University and the Second People's Hospital of Huai'an Huai'an China.

ORCID-Profile: Xiaye Miao

Zitieren

APA

Huang, Y., Zhang, C., Xie, X., Miao, X., & Quan, Z. (2026). Single‐Cell and Bulk Transcriptomic Profiling of Urothelial Carcinoma: Immunotherapy Associations and Functional Characterization of LY6E. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/8444243

Vancouver

Huang Y, Zhang C, Xie X, Miao X, Quan Z. Single‐Cell and Bulk Transcriptomic Profiling of Urothelial Carcinoma: Immunotherapy Associations and Functional Characterization of LY6E. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/8444243

BibTeX
@article{Huang2026,
  author = {Huang, Yitao and Zhang, Chao and Xie, Xiuzhuang and Miao, Xiaye and Quan, Zhang},
  title = {Single‐Cell and Bulk Transcriptomic Profiling of Urothelial Carcinoma: Immunotherapy Associations and Functional Characterization of LY6E},
  journal = {International Journal of Genomics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ijog/8444243}
}
Kostenlos starten →